Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota
Purpose
The purpose of this epidemiologic study is to estimate the prevalence and incidence of anti-SARS-CoV-2 antibodies in at-risk, exposed, affected populations. The study will also estimate the risk of SARS-CoV-2 exposure in target population.
Conditions
- Covid19
- SARS-CoV Infection
- SARS-CoV-2
- Corona Virus Infection
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Participants in Group 1 (General Healthy Population) must have no known exposure to SARS-CoV-2 and have not sought medical help in the previous 4 months for SARS-CoV-2-related symptoms - Participants in Group 2 must be currently enrolled in a medical residency program - Participants in Group 3 must currently test positive for HIV infection
Exclusion Criteria
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the participant or the quality of the data (e.g., someone not able to answer the questionnaire because of a psychological condition or an anxiety disorder that is severe). - Contraindication for routine blood draws (e.g., severe anemia, hemophilia, etc)
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
General Healthy Population | Participants in this group are part of the general healthy population of adults 18 years-of-age and older, not known to be exposed to the virus as reported by potential participants and who have not sought medical help in the previous 4 months. |
|
Medical School Residents | Participants in this group are medical school residents. |
|
Individuals who are HIV positive | Participants in this group are HIV positive. |
|
Recruiting Locations
More Details
- NCT ID
- NCT04473183
- Status
- Withdrawn
- Sponsor
- University of Minnesota
Detailed Description
This study is not for real-time diagnostic purposes, guidance for patient care, or the development of a diagnostic test. The research tests performed for this study will not be prioritized over clinical care samples, that research samples will be batched and tested after clinical care samples. This study is a population-based epidemiologic analysis of prevalence of various groups of persons. Group (1) general healthy population. People 18 years of age and older that have not tested positive for SARS-CoV-2 and who have not sought medical help in the previous 4 months. Group (2) Medical School Residents , 18 years of age and older that have not tested positive for SARS-CoV-2 Group (3) Individuals who are HIV positive. People 18 years of age and older that have not tested positive for SARS-CoV-2